In updated 2025 American Society of Hematology guidelines, recommendations are presented for the management of newly ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

The chemotherapy-free regimen achieved higher remission, better survival, and stronger molecular responses than the ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

ORLANDO -- Azacitidine and venetoclax (Venclexta) significantly improved event-free survival (EFS) in newly diagnosed fit ...

A major breakthrough in the treatment of an aggressive form of leukemia is bringing new hope to patients and it started in ...

Review of current and emerging treatments for older adults with acute myeloid leukemia, highlighting venetoclax plus ...

While patients with acute myeloid leukemia (AML) are routinely treated with chemotherapy and other cell-killing therapies, ...

A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective as standard of care (SoC) in a ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...